new IV bisphosphonate called Zometa (zoledronic acid)

Novartis will soon market a new IV bisphosphonate called Zometa (zoledronic acid).

It will be used as an alternative to Aredia (pamidronate)... for hypercalcemia and bone metastases in cancer patients.

Bisphosphonates help lower serum calcium by inhibiting bone resorption. They also reduce bone pain and fractures in patients with bone metastases.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote